Brevan Howard Capital Management’s Halozyme HALO Stock Holding History

Brevan Howard Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$354K	Buy	+4,528	New	+$309K	﹤0.01%	1614
2025 Q4	–	Sell	-64,217	Closed	-$4.71M	–	1999
2025 Q3	$4.71M	Sell	64,217 -96,806	-60%	-$6.43M	0.02%	251
2025 Q2	$8.38M	Buy	161,023 +145,807	+958%	+$8.3M	0.05%	226
2025 Q1	$971K	Sell	15,216 -5,780	-28%	-$336K	0.01%	506
2024 Q4	$1M	Buy	+20,996	New	+$1.08M	0.01%	436
2024 Q3	–	Sell	-19,808	Closed	-$1.04M	–	1258
2024 Q2	$1.04M	Buy	+19,808	New	+$869K	0.01%	361
2024 Q1	–	Sell	-9,294	Closed	-$344K	–	1132
2023 Q4	$344K	Buy	+9,294	New	+$350K	﹤0.01%	658

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Brevan Howard Capital Management's HALO Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Halozyme (HALO) in Q2 2026: 4,528 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #1614 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in HALO as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in HALO in Q4 2023 and has held it in 7 quarters since. The position peaked at $8.38M in Q2 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Brevan Howard Capital Management held 4,528 shares of Halozyme worth $354K as of Q2 2026.
Halozyme was a new Brevan Howard Capital Management position in Q2 2026.
Halozyme made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1614 holding.
Brevan Howard Capital Management first reported a position in Halozyme in Q4 2023 and has held it in 7 quarters since.
Brevan Howard Capital Management's Halozyme position peaked at $8.38M in Q2 2025.
674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.